相似文献
1
Caspofungin: cross-reactivity in the Aspergillus antigen assay.
J Clin Microbiol. 2010 Jun;48(6):2313. doi: 10.1128/JCM.00118-10. Epub 2010 Mar 31.
2
Immediate cross-hypersensitivity between micafungin and caspofungin: a case report.
J Oncol Pharm Pract. 2009 Sep;15(3):187-9. doi: 10.1177/1078155208101122. Epub 2009 Mar 10.
3
Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.
Clin Infect Dis. 2006 Aug 1;43(3):e23-5. doi: 10.1086/505603. Epub 2006 Jun 19.
4
Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study.
Clin Infect Dis. 2005 Jul 1;41(1):e9-14. doi: 10.1086/430826. Epub 2005 May 17.
5
Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Med Mycol. 2005 Nov;43(7):651-5. doi: 10.1080/13693780500271772.
6
[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review].
Rev Iberoam Micol. 2007 Jun;24(2):157-60. doi: 10.1016/s1130-1406(07)70034-7.
7
Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation.
J Heart Lung Transplant. 2008 Jan;27(1):1-6. doi: 10.1016/j.healun.2007.10.002.
8
Caspofungin acetate for treatment of invasive fungal infections.
Ann Pharmacother. 2003 Jan;37(1):90-8. doi: 10.1345/aph.1C114.
9
Well-characterized monoclonal antibodies against cell wall antigen of Aspergillus species improve immunoassay specificity and sensitivity.
Clin Vaccine Immunol. 2008 Feb;15(2):194-202. doi: 10.1128/CVI.00362-07. Epub 2007 Nov 21.
10
Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin.
Clin Microbiol Infect. 2003 Dec;9(12):1238-41. doi: 10.1111/j.1469-0691.2003.00797.x.
引用本文的文献
1
Implications for the diagnosis of aspiration and aspergillosis in critically ill patients with detection of galactomannan in broncho-alveolar lavage fluids.
Sci Rep. 2025 Jan 15;15(1):1997. doi: 10.1038/s41598-025-85644-5.
2
An invasive infection caused by the thermophilic mold Talaromyces thermophilus.
Infection. 2021 Dec;49(6):1347-1353. doi: 10.1007/s15010-021-01648-z. Epub 2021 Jun 30.
3
Case report: Enteral nutritional supplement as a likely cause of false-positive galactomannan testing.
Med Mycol Case Rep. 2013 Dec 16;3:11-3. doi: 10.1016/j.mmcr.2013.11.004. eCollection 2014 Jan.
本文引用的文献
1
Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay.
Diagn Microbiol Infect Dis. 2007 Sep;59(1):113-5. doi: 10.1016/j.diagmicrobio.2007.04.022. Epub 2007 Jul 26.
2
Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.
Clin Infect Dis. 2006 Aug 1;43(3):e23-5. doi: 10.1086/505603. Epub 2006 Jun 19.
3
False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.
N Engl J Med. 2003 Dec 11;349(24):2366-7. doi: 10.1056/NEJM200312113492424.
4
Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.
Blood. 2001 Mar 15;97(6):1604-10. doi: 10.1182/blood.v97.6.1604.
5
Detection of Aspergillus galactomannan antigen in foods and antibiotics.
Mycoses. 1997 Dec;40(9-10):353-7. doi: 10.1111/j.1439-0507.1997.tb00249.x.
Zotero 插件